Logo Tarian Pharma
Discover Tarian Gel

Protecting What Matters,

Every Step of the Way

Unlock full cancer treatment potential by preventing dose-limiting skin side effects

Discover Tarian Gel

Preventing Severe Skin Toxicities Associated With Cancer Treatments

Our Company

Tarian is a privately owned clinical-stage pharmaceutical company developing targeted solutions to prevent severe skin toxicities associated with cancer therapies which are a major cause of dose reductions, treatment delays, reduced patient adherence and diminished quality of life. By addressing this critical unmet need, Tarian aims to improve treatment outcomes and unlock greater therapeutic value across oncology pipelines.

Our Drug Candidate

TAR-0520 (Tarian Gel) is a topical, extended-release formulation of brimonidine tartrate that mimics the mechanism of cooling devices by inducing localized, transient vasoconstriction. Tar-0520 is protected by multiple patents that include method of use and composition of matter.

Development Status

Tarian gel is currently investigated in three clinical phase 2 studies:
1. EGFR-induced folliculitis in metastatic colorectal cancer,
2. Taxane-induced peripheral neuropathy in breast cancer,
3. Capecitabine-induced Hand and Foot syndrome in colorectal and breast cancer. Results of these studies are expected by the end of 2026.

A New Era in Supportive Cancer Care

Protecting skin. Preserving dignity. Empowering treatment continuity.

At Tarian Pharma We Believe That Real Innovation Cares
OUR PHILOSOPHY

At Tarian Pharma,
We Believe That Real Innovation Cares

We envision a future where supportive care in oncology is proactive, science-driven, and patient-centered, enabling individuals to complete their cancer treatment with fewer dermatological side effects and improved survival and increased remission rates. Patients undergoing cancer treatment face more than the disease itself: they face a cascade of dermatological side effects that affect comfort, self-esteem, and the ability to complete treatment.
We developed a one and only product: a topical shield designed to actively protect the skin, improve quality of life, and enhance adherence to cancer therapy. It’s not just a product. It’s the guardian of your skin — Simple yet essential.
More about us
Tarian Gel

The Shield That Supports

Unlike traditional add-ons, our product is not burdensome. It’s light, adaptable, and medically aligned with real-world protocols.
Picto Tarian Pharma

One and Only Product

Scientifically developed to reinforce cancer treatments rather than disrupt them.
Picto Tarian Pharma

Once-a-Day Routine

A simple, portable gesture that fits naturally into everyday life.
Picto Tarian Pharma

Evidence-Based Innovation

Built on over 200 formulation prototypes, tested and validated by oncology experts.
More about Tarian Gel
The Shield That Supports Not Interrupts
Key figures

Skin Side Effects:
A Widespread and Undervalued Burden

Up to 90% of patients undergoing chemotherapy or targeted therapies develop skin side effects such as dryness, rashes, or irritation affecting not just physical comfort, but also confidence, daily life, and treatment adherence. 1

Up to 30% of cancer patients consider modifying or discontinuing their treatment due to skin-related toxicities. Despite their frequency and clinical relevance, skin side effects remain one of the most under-addressed dimensions of oncology care.

1. Lacouture et al. (2021), The Oncologist

We protect without interfering.

We support without asking.

We act without complicating.


We are the guardian of oncology patients,
always there, always caring.

At the Heart of Our Purpose

At Tarian Pharma, we stand at the intersection of science and empathy — committed to protecting patients, supporting clinicians, and shaping a future where cancer care is not only effective, but profoundly human.

What drives us

A Seamless Addition to Oncology Protocols

Our solution isn’t just patient-friendly — it’s also designed for seamless integration into oncology protocols.
Simple and compatible, it helps clinicians focus on what matters most: remission, recovery, and results. It improves compliance, reduces interruptions, and supports overall treatment success.

Contact

Our Protective Innovation in Action

At Tarian Pharma, our purpose focuses on one concrete solution: Tarian Gel, our oncogical support shield.
Engineered with science, designed with empathy, and built to preserve treatment continuity — it represents everything we stand for.

Discover Tarian Gel
Logo Tarian Pharma

© Tarian Pharma 2025

Privacy policy

Phase 1 data : MASCC Conference Poster